vs
CVRx, Inc.（CVRX）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是CVRx, Inc.的1.6倍（$25.9M vs $16.0M），REDWOOD TRUST INC净利率更高（77.2% vs -74.5%，领先151.7%），CVRx, Inc.同比增速更快（4.4% vs -6.1%），过去两年CVRx, Inc.的营收复合增速更高（22.0% vs -41.0%）
CVRx, Inc.是一家处于商业化阶段的医疗科技企业，专注于慢性心血管疾病神经调节疗法的研发与商业化，旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压，核心市场覆盖北美、欧洲，服务对常规药物治疗应答不佳的患者。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
CVRX vs RWT — 直观对比
营收规模更大
RWT
是对方的1.6倍
$16.0M
营收增速更快
CVRX
高出10.5%
-6.1%
净利率更高
RWT
高出151.7%
-74.5%
两年增速更快
CVRX
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.0M | $25.9M |
| 净利润 | $-11.9M | $20.0M |
| 毛利率 | 86.3% | — |
| 营业利润率 | -69.8% | — |
| 净利率 | -74.5% | 77.2% |
| 营收同比 | 4.4% | -6.1% |
| 净利润同比 | -12.0% | 402.6% |
| 每股收益（稀释后） | $-0.45 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVRXRWT
| Q4 25 | $16.0M | $25.9M | ||
| Q3 25 | $14.7M | $15.0M | ||
| Q2 25 | $13.6M | $13.8M | ||
| Q1 25 | $12.3M | $27.9M | ||
| Q4 24 | $15.3M | $27.6M | ||
| Q3 24 | $13.4M | $25.5M | ||
| Q2 24 | $11.8M | $67.4M | ||
| Q1 24 | $10.8M | $74.5M |
净利润CVRXRWT
| Q4 25 | $-11.9M | $20.0M | ||
| Q3 25 | $-12.9M | $-7.7M | ||
| Q2 25 | $-14.7M | $-98.5M | ||
| Q1 25 | $-13.8M | $16.1M | ||
| Q4 24 | $-10.7M | $-6.6M | ||
| Q3 24 | $-13.1M | $14.8M | ||
| Q2 24 | $-14.0M | $15.5M | ||
| Q1 24 | $-22.2M | $30.3M |
毛利率CVRXRWT
| Q4 25 | 86.3% | — | ||
| Q3 25 | 86.8% | — | ||
| Q2 25 | 84.3% | — | ||
| Q1 25 | 83.5% | — | ||
| Q4 24 | 83.2% | — | ||
| Q3 24 | 83.2% | — | ||
| Q2 24 | 83.9% | — | ||
| Q1 24 | 85.0% | — |
营业利润率CVRXRWT
| Q4 25 | -69.8% | — | ||
| Q3 25 | -83.5% | -9.0% | ||
| Q2 25 | -105.8% | -679.0% | ||
| Q1 25 | -108.8% | 80.2% | ||
| Q4 24 | -67.0% | -1.3% | ||
| Q3 24 | -97.3% | 86.1% | ||
| Q2 24 | -118.3% | 30.3% | ||
| Q1 24 | -206.4% | 41.3% |
净利率CVRXRWT
| Q4 25 | -74.5% | 77.2% | ||
| Q3 25 | -87.6% | -51.4% | ||
| Q2 25 | -108.4% | -712.0% | ||
| Q1 25 | -111.5% | 57.8% | ||
| Q4 24 | -69.4% | -24.0% | ||
| Q3 24 | -98.0% | 58.1% | ||
| Q2 24 | -118.8% | 23.0% | ||
| Q1 24 | -206.0% | 40.6% |
每股收益（稀释后）CVRXRWT
| Q4 25 | $-0.45 | $0.11 | ||
| Q3 25 | $-0.49 | $-0.08 | ||
| Q2 25 | $-0.57 | $-0.76 | ||
| Q1 25 | $-0.53 | $0.10 | ||
| Q4 24 | $-0.39 | $-0.08 | ||
| Q3 24 | $-0.57 | $0.09 | ||
| Q2 24 | $-0.65 | $0.10 | ||
| Q1 24 | $-1.04 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.3M | $982.6M |
| 总资产 | $104.8M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVRXRWT
| Q4 25 | $75.7M | $255.7M | ||
| Q3 25 | $85.1M | $226.3M | ||
| Q2 25 | $95.0M | $302.0M | ||
| Q1 25 | $102.7M | $259.9M | ||
| Q4 24 | $105.9M | $245.2M | ||
| Q3 24 | $100.2M | $253.7M | ||
| Q2 24 | $70.4M | $275.6M | ||
| Q1 24 | $80.1M | $275.4M |
总债务CVRXRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益CVRXRWT
| Q4 25 | $39.3M | $982.6M | ||
| Q3 25 | $48.1M | $999.0M | ||
| Q2 25 | $57.9M | $1.1B | ||
| Q1 25 | $71.1M | $1.2B | ||
| Q4 24 | $71.1M | $1.2B | ||
| Q3 24 | $65.2M | $1.2B | ||
| Q2 24 | $55.2M | $1.2B | ||
| Q1 24 | $66.3M | $1.2B |
总资产CVRXRWT
| Q4 25 | $104.8M | $23.7B | ||
| Q3 25 | $111.3M | $22.6B | ||
| Q2 25 | $119.6M | $21.3B | ||
| Q1 25 | $129.6M | $19.9B | ||
| Q4 24 | $133.4M | $18.3B | ||
| Q3 24 | $127.7M | $18.4B | ||
| Q2 24 | $96.0M | $16.5B | ||
| Q1 24 | $106.2M | $15.1B |
负债/权益比CVRXRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | — |
| 自由现金流率自由现金流/营收 | -61.3% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-40.8M | — |
8季度趋势，按日历期对齐
经营现金流CVRXRWT
| Q4 25 | $-9.8M | $-10.1B | ||
| Q3 25 | $-9.7M | $-2.7B | ||
| Q2 25 | $-7.9M | $-2.1B | ||
| Q1 25 | $-12.8M | $-2.0B | ||
| Q4 24 | $-8.0M | $-5.9B | ||
| Q3 24 | $-10.4M | $-2.1B | ||
| Q2 24 | $-9.8M | $-2.0B | ||
| Q1 24 | $-10.9M | $-954.2M |
自由现金流CVRXRWT
| Q4 25 | $-9.8M | — | ||
| Q3 25 | $-10.0M | — | ||
| Q2 25 | $-8.0M | — | ||
| Q1 25 | $-12.9M | — | ||
| Q4 24 | $-8.1M | — | ||
| Q3 24 | $-10.4M | — | ||
| Q2 24 | $-10.2M | — | ||
| Q1 24 | $-11.8M | — |
自由现金流率CVRXRWT
| Q4 25 | -61.3% | — | ||
| Q3 25 | -68.1% | — | ||
| Q2 25 | -59.2% | — | ||
| Q1 25 | -104.3% | — | ||
| Q4 24 | -52.5% | — | ||
| Q3 24 | -78.1% | — | ||
| Q2 24 | -86.3% | — | ||
| Q1 24 | -109.7% | — |
资本支出强度CVRXRWT
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 8.5% | — |
现金转化率CVRXRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
RWT
暂无分部数据
